Larimar Therapeutics (LRMR) News Today $3.20 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LRMR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Analysts Set Larimar Therapeutics, Inc. (NASDAQ:LRMR) PT at $18.50July 4 at 2:23 AM | americanbankingnews.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Buy" by BrokeragesJuly 1, 2025 | marketbeat.comWedbush Research Analysts Reduce Earnings Estimates for LRMRJune 28, 2025 | americanbankingnews.comResearch Analysts Issue Forecasts for LRMR FY2025 EarningsJune 27, 2025 | americanbankingnews.comResearch Analysts Issue Forecasts for LRMR Q2 EarningsJune 27, 2025 | americanbankingnews.comWedbush Predicts Reduced Earnings for Larimar TherapeuticsJune 26, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for LRMR FY2026 Earnings?June 26, 2025 | marketbeat.comFY2025 Earnings Estimate for LRMR Issued By Lifesci CapitalJune 26, 2025 | marketbeat.comEquities Analysts Issue Forecasts for LRMR Q2 EarningsJune 25, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and Larimar Therapeutics (LRMR)June 24, 2025 | theglobeandmail.comWedbush Issues Pessimistic Forecast for Larimar Therapeutics (NASDAQ:LRMR) Stock PriceJune 24, 2025 | marketbeat.comLarimar Therapeutics (NASDAQ:LRMR) Given Buy Rating at GuggenheimJune 24, 2025 | marketbeat.comLarimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich's Ataxia ProgramJune 23, 2025 | globenewswire.comLarimar Therapeutics to Host Conference Call on Regulatory Updates for Nomlabofusp Clinical Development ProgramJune 22, 2025 | nasdaq.comLarimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s AtaxiaJune 20, 2025 | finance.yahoo.comLarimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich's AtaxiaJune 20, 2025 | globenewswire.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Short Interest UpdateJune 16, 2025 | marketbeat.comMillennium Management LLC Sells 508,912 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR)June 6, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Given Average Rating of "Buy" by BrokeragesJune 6, 2025 | marketbeat.comDeutsche Bank AG Sells 238,010 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR)June 3, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Short Interest Up 64.7% in MayJune 1, 2025 | marketbeat.comWoodline Partners LP Sells 621,869 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR)May 27, 2025 | marketbeat.comLarimar Therapeutics’ SWOT analysis: nomlabofusp’s potential lifts FA stockMay 24, 2025 | investing.comLarimar Therapeutics, Inc.’s (LRMR): Analysts See 957% Upside PotentialMay 21, 2025 | insidermonkey.comJanus Henderson Group PLC Increases Stake in Larimar Therapeutics, Inc. (NASDAQ:LRMR)May 18, 2025 | marketbeat.comCubist Systematic Strategies LLC Boosts Stock Position in Larimar Therapeutics, Inc. (NASDAQ:LRMR)May 17, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Buy" from AnalystsMay 13, 2025 | marketbeat.comDAFNA Capital Management LLC Cuts Position in Larimar Therapeutics, Inc. (NASDAQ:LRMR)May 10, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Shares Purchased by Alyeska Investment Group L.P.May 8, 2025 | marketbeat.comLeerink Partnrs Issues Positive Estimate for LRMR EarningsMay 6, 2025 | marketbeat.comQ2 EPS Estimate for Larimar Therapeutics Reduced by AnalystMay 6, 2025 | marketbeat.comWilliam Blair Issues Positive Outlook for LRMR EarningsMay 6, 2025 | marketbeat.comLarimar Therapeutics Advances Nomlabofusp Amid Financial LossMay 4, 2025 | tipranks.comBrokers Set Expectations for LRMR Q2 EarningsMay 4, 2025 | marketbeat.comLarimar Therapeutics Reports Q1 2025 Results and Advances Nomlabofusp DevelopmentMay 4, 2025 | msn.comLarimar Therapeutics (LRMR) Projected to Post Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Shares Acquired by Adage Capital Partners GP L.L.C.May 1, 2025 | marketbeat.comLarimar Therapeutics Reports First Quarter 2025 Financial ResultsApril 30, 2025 | globenewswire.comRenaissance Technologies LLC Purchases 159,700 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR)April 28, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Shares Bought by Blue Owl Capital Holdings LPApril 26, 2025 | marketbeat.comLarimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Buy" by AnalystsApril 18, 2025 | marketbeat.comLarimar Therapeutics: Initiating Hold Rating With Upcoming CatalystsApril 4, 2025 | seekingalpha.comHC Wainwright Brokers Decrease Earnings Estimates for LRMRMarch 28, 2025 | marketbeat.comQ1 EPS Estimate for Larimar Therapeutics Reduced by AnalystMarch 28, 2025 | marketbeat.comLarimar Therapeutics Advances Nomlabofusp Program Amid Regulatory SupportMarch 27, 2025 | msn.comAnalysts Offer Predictions for LRMR Q1 EarningsMarch 27, 2025 | marketbeat.comEquities Analysts Offer Predictions for LRMR Q1 EarningsMarch 27, 2025 | marketbeat.comGuggenheim Reaffirms Buy Rating for Larimar Therapeutics (NASDAQ:LRMR)March 26, 2025 | marketbeat.comLarimar Therapeutics (NASDAQ:LRMR) Price Target Cut to $10.00 by Analysts at Robert W. BairdMarch 26, 2025 | marketbeat.comLarimar Therapeutics (NASDAQ:LRMR) Stock Price Expected to Rise, HC Wainwright Analyst SaysMarch 26, 2025 | marketbeat.com Get Larimar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter. Email Address LRMR Media Mentions By Week LRMR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LRMR News Sentiment▼0.830.57▲Average Medical News Sentiment LRMR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LRMR Articles This Week▼23▲LRMR Articles Average Week Get Larimar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cronos Group News Xeris Biopharma News Pharming Group News Replimune Group News Vir Biotechnology News Gyre Therapeutics News Phathom Pharmaceuticals News Nuvation Bio News Ginkgo Bioworks News Day One Biopharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LRMR) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Larimar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
